Brian P. Reilly ’85

Brian P. Reilly ’85 has been appointed to the Board of Directors of Chimera Investment Corporation, Inc. (NYSE: CIM). Mr. Reilly will serve as a Class III Director and will stand for election at the Company’s 202 shareholder meeting for the remaining two years of the Class III Director term. He will also serve on the Audit Committee, as a Financial Expert, and the Risk Committee of the Company’s Board of Directors.

George D. Morton III ’85

George D. Morton III ’85 has been selected as the regional human resources director for Pelican Products, Inc.’s South Deerfield, Massachusetts office. Pelican Products, Inc. is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco. In his new position, Mr. Morton will be responsible for managing tactical human resources, delivering on strategic operational goals, leading workforce planning and engaging employees for Pelican’s Eastern region.

Joanne C. Crevoiserat’85

Joanne C. Crevoiserat ’85 has been named the Chief Financial Officer of Tapestry, Inc. (NYSE: TPR), a leading New York-based house of modern luxury accessories and lifestyle brands.  It’s portfolio includes Coach, Kate Spade and Stuart Weitzman.  Ms. Crevoiserat joins Tapestry from Abercrombie & Fitch and has also held senior finance positions with Kohl’s Inc, Wal-Mart Stores and May Department Stores.

Richard S. Martin ’86

Richard S. Martin ’86 has joined RentPath as Chief Financial Officer.  Prior to joining RentPath, Mr. Martin served as CFO of Symphony Health Solutions and was responsible for accounting, FP&A, risk management, tax and treasury.  He brings a wealth of experience to the role, as well as functional expertise in metrics-based management, working capital management and strategy & growth.

Richard C. Hague ’83

Richard C. Hague ’83 has joined Polarity TE as the Company’s Chief Operating Officer.  Mr. Hague brings to PolarityTE experience in many aspects of corporate development and operations from his more than 30-year career in the biotechnology industry, including launching a variety of autologous cell and tissue therapies.